Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hair follicle growth factor pathways represent a complex, integrated network of signaling cascades that govern the cyclic transformation of the hair follicle through anagen (growth), catagen (regression), and telogen (quiescence) phases (StatPearls, PMID: 30252371). Central to these pathways are the Wnt/beta-catenin and Sonic Hedgehog (Shh) cascades, which are essential for follicle morphogenesis and the transition from telogen to anagen (Huelsken et al., 2001, PMID: 11486082; St-Jacques et al., 1998, PMID: 9693014). Growth factors such as Insulin-like Growth Factor-1 (IGF-1), Fibroblast Growth Factor-7 (FGF-7/KGF), and Vascular Endothelial Growth Factor (VEGF) act as paracrine signals from the dermal papilla to promote hair shaft elongation and perifollicular vascularization (Danilenko et al., 1995, PMID: 7715875; Lachgar et al., 1998, PMID: 9589201). Conversely, inhibitory signals like TGF-beta and FGF-5 serve to terminate the growth phase and induce catagen (Foitzik et al., 2000, PMID: 10644311). In conditions such as androgenetic alopecia, the balance of these pathways is disrupted—often by dihydrotestosterone (DHT)—leading to follicle miniaturization and a progressively shortened anagen phase. Therapeutic interventions like Minoxidil and various JAK inhibitors aim to restore these pathways to favor hair growth and follicle maintenance (Messenger & Rundegren, 2004, PMID: 15034194; King et al., 2022, PMID: 35334197).
Modulation of the hair follicle cycle by stimulating anagen (growth) phase entry, prolonging anagen duration, or inhibiting catagen (regression) induction through the activation of growth-promoting signals (e.g., Wnt, Shh, IGF-1) or the inhibition of growth-arresting factors (e.g., TGF-beta, FGF-5, DKK-1).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hair follicle growth factor pathways.